ASND (Ascendis Pharma AS) 5-Year EBITDA Growth Rate : 0.40% (As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Ascendis Pharma AS 5-Year EBITDA Growth Rate?

Ascendis Pharma AS's EBITDA per Share for the three months ended in Dec. 2024 was $-0.66.

During the past 3 years, the average EBITDA Per Share Growth Rate was 11.30% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 0.40% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was -22.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Ascendis Pharma AS was 11.30% per year. The lowest was -82.50% per year. And the median was -26.90% per year.

Competitive Comparison of Ascendis Pharma AS's 5-Year EBITDA Growth Rate

For the Biotechnology subindustry, Ascendis Pharma AS's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ascendis Pharma AS's 5-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ascendis Pharma AS's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Ascendis Pharma AS's 5-Year EBITDA Growth Rate falls into.

Save Embed

;

Save Embed

;

Ascendis Pharma AS 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Ascendis Pharma AS (NAS:ASND) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Ascendis Pharma AS 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Ascendis Pharma AS's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Ascendis Pharma AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascendis Pharma AS (NAS:ASND) » Definitions » 5-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

ASND:Mexico A71:Germany A1SN34:Brazil

Address

Tuborg Boulevard 12, Hellerup, DNK, DK-2900

Website

https://www.ascendispharma.com

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.